lactic acid has been researched along with carmustine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Carpinelli, AR; Dufrane, SP; Garcia-Morales, P; Malaisse, WJ; Malaisse-Lagae, F; Mathias, PC; Sener, A; Valverde, I | 1 |
| Benoit, JP; Painbeni, T; Venier-Julienne, MC | 1 |
| Breitkreutz, R; Dröge, W; Hehner, SP; Schmitz, ML; Schulze-Osthoff, K; Shubinsky, G; Unsoeld, H | 1 |
| An, TK; Choi, SU; Khang, G; Lee, CO; Lee, HB; Seong, H | 1 |
| An, TK; Chae, GS; Cho, SH; Jeong, JK; Khang, G; Lee, HB; Lee, JS | 1 |
| Chae, GS; Khang, G; Kim, MS; Kim, SH; Lee, HB; Lee, JS; Seo, KS | 1 |
| Chen, X; Jing, X; Lu, T; Wang, X; Xu, X; Yang, L | 1 |
| Brem, H; Cima, MJ; Karp, JM; Kim, GY; Langer, RS; Tupper, MM; Tyler, BM | 1 |
| Jin, T; Wu, F; Xu, L; Yuan, W | 1 |
| Esther Gil-Alegre, M; González-Alvarez, I; Gutiérrez-Paúls, L; Torres-Suárez, AI | 1 |
| Albadany, A; Chang, J; Guo, Y; Kang, C; Li, Y; Pu, P; Sheng, J; Yu, S; Yuan, X; Zhang, Z; Zhong, Y | 1 |
| Chen, WA; Kao, YC; Liao, JY; Liu, SJ; Tseng, YY | 1 |
| Abidian, MR; Borhan, A; Fattahi, P | 1 |
15 other study(ies) available for lactic acid and carmustine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
The coupling of metabolic to secretory events in pancreatic islets. The possible role of glutathione reductase.
Topics: Animals; Calcium; Carmustine; Cyclic AMP; Glutamine; Glutathione; Glutathione Reductase; Insulin; Islets of Langerhans; Lactates; Lactic Acid; Leucine; Oxidation-Reduction; Pyruvates; Pyruvic Acid; Rats | 1985 |
Internal morphology of poly(D,L-lactide-co-glycolide) BCNU-loaded microspheres. Influence on drug stability.
Topics: Antineoplastic Agents; Biocompatible Materials; Carmustine; Drug Carriers; Drug Compounding; Drug Stability; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solvents | 1998 |
Enhancement of T cell receptor signaling by a mild oxidative shift in the intracellular thiol pool.
Topics: Antibodies, Monoclonal; Carmustine; CD28 Antigens; Enzyme Activation; Genes, Reporter; Humans; Hydrogen Peroxide; I-kappa B Kinase; Interleukin-2; Intracellular Fluid; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Lactic Acid; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mitogen-Activated Protein Kinases; Muromonab-CD3; NF-kappa B; Oxidation-Reduction; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Receptors, Antigen, T-Cell; Response Elements; Signal Transduction; Sulfhydryl Compounds; T-Lymphocytes; Transcription, Genetic | 2000 |
BCNU-loaded poly(D, L-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro.
Topics: Antineoplastic Agents, Alkylating; Carmustine; Central Nervous System Neoplasms; Drug Carriers; Drug Screening Assays, Antitumor; Humans; Lactic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Tumor Cells, Cultured | 2003 |
Evaluation of in vitro and in vivo antitumor activity of BCNU-loaded PLGA wafer against 9L gliosarcoma.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Line, Tumor; Cell Survival; Drug Evaluation, Preclinical; Gliosarcoma; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Inbred F344 | 2005 |
Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Drug Stability; Drug Storage; Emulsions; Excipients; Gliosarcoma; Humans; Lactic Acid; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2005 |
BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Stability; Glioma; Lactic Acid; Polyesters; Polyethylene Glycols; Polymers; Rats; Solubility | 2006 |
Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
Topics: Animals; Antineoplastic Agents, Alkylating; Biocompatible Materials; Carmustine; Chemistry, Pharmaceutical; Decanoic Acids; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Implants; Drug Stability; Female; Gliosarcoma; Half-Life; Lactic Acid; Nanotechnology; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Inbred F344; Reproducibility of Results; Solubility; Time Factors | 2007 |
Controlled-release implant system formulated using biodegradable hemostatic gauze as scaffold.
Topics: Absorbable Implants; Antineoplastic Agents, Alkylating; Calorimetry, Differential Scanning; Carmustine; Cellulose, Oxidized; Crystallization; Delayed-Action Preparations; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Surface Properties; Tissue Scaffolds; X-Ray Diffraction | 2008 |
Three weeks release BCNU loaded hydrophilic-PLGA microspheres for interstitial chemotherapy: Development and activity against human glioblastoma cells.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Cell Survival; Drug Carriers; Glioblastoma; Humans; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Time Factors; Tumor Cells, Cultured | 2008 |
Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(D,L-lactic acid) nanoparticles.
Topics: Animals; Brain Neoplasms; Carmustine; Cell Line, Tumor; Glioma; Lactic Acid; Male; Nanoparticles; Polyesters; Polymers; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques | 2009 |
Sustainable release of carmustine from biodegradable poly[((D,L))-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity: in vitro and in vivo studies.
Topics: Absorbable Implants; Animals; Antineoplastic Agents, Alkylating; Biocompatible Materials; Biological Availability; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Cerebral Cortex; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Carriers; Drug Implants; Lactic Acid; Nanofibers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar | 2013 |
Microencapsulation of chemotherapeutics into monodisperse and tunable biodegradable polymers via electrified liquid jets: control of size, shape, and drug release.
Topics: Antineoplastic Agents; Carmustine; Drug Compounding; Drug Delivery Systems; Lactic Acid; Microfluidics; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2013 |